Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry

Author(s)	Sandeep Ramanamuni
Country	United States
Abstract	This paper highlights how digital transformation is critical in developing a competitive edge and capabilities in Contract Development and Manufacturing Organizations within the pharmaceutical industry. The fact that there is increased international demand for innovative and personalized medicines puts CDMOs under pressure to provide quicker, more efficient, and more compliant services. Such research underscores how digitalization, via technologies such as ML, the IoT, digital twins, AI, and cloud-based systems, can help CDMOs streamline their operations and improve supply chain visibility and time to market. The paper further sheds light on a digital-first mindset, cybersecurity, solid data integration, and end-to-end transparency as the bases for value delivery and sustainable growth within the pharmaceutical landscape.
Keywords	digital transformation, pharmaceutical industry, CDMO, supply chain visibility, AI, IoT, digital technologies.
Field	Engineering
Published In	Volume 15, Issue 4, October-December 2024
Published On	2024-11-06
DOI	https://doi.org/10.71097/IJSAT.v15.i4.2834

About IJSAT Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us	Message on WhatsApp	+91-9687-182-185	editor@ijsat.org

International Journal on Science and Technology